Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/projekte/827-etop-15-19-abc-lung-a-randomised-non-comparative-open-label-phase-ii-trial-of-atezolizumab-plus-bevacizumab-with-carboplatin-paclitaxel-or-pemetrexed-in-egfr-mutant-non-small-cell-lung-carci-noma-with-acquired-resistance-abc-lung